EMULSION COMPOSITION FOR TOPICAL USE CONTAINING NON-STEROID ANTI-INFLAMMATORY AGENT Russian patent published in 2023 - IPC A61K9/00 A61K31/00 A61K47/14 

Abstract RU 2804418 C2

FIELD: pharmaceutical industry.

SUBSTANCE: group of inventions relates to a composition for the treatment of pain. Emulsion composition for the treatment of pain, selected from the group including pain in the joints, bones, ligaments, tendons and muscles contains the following: (i) from 7 to 15 wt.% of a non-steroidal anti-inflammatory drug; (ii) from 15 to 50 wt.% of isopropyl myristate; (iii) from 25 to 50.2 wt.% of water; (iv) one or more emulsifiers; (v) one or more pH adjusters; and (vi) one or more solubilizers, wherein the said emulsion composition contains 5 or less wt.% of C1-C4 alcohols, one or more pH adjusters include diethylamine, one or more solubilizers include propylene glycol, the said non-steroidal anti-inflammatory drug is selected from the group consisting of ibuprofen, ketoprofen, diclofenac, and the said emulsion composition has a pH in the range of 5 to 7. A method of treating pain in joints, bones, ligaments, tendons and muscles in a subject is characterized by the following: the composition according to claim 1 is applied dermally at a dosage of 2.67 g, which corresponds to 200 mg of ibuprofen, once to the said subject.

EFFECT: above composition is effective for the treatment of pain selected from the group including pain in the joints, bones, ligaments, tendons and muscles, is characterized by increased bioavailability, stability, while the composition has a lower degree of conversion of ibuprofen to ibuprofen-propylene glycol ester.

7 cl, 4 tbl, 2 ex

Similar patents RU2804418C2

Title Year Author Number
COMPOSITIONS AND METHODS FOR ENHANCING TOPICAL APPLICATION OF ACIDIC BENEFIT AGENT 2015
  • Sun, Ying
  • Wu, Jeffrey M.
  • Fassih, Ali
RU2683779C2
COMPOSITIONS AND METHODS OF INCREASING EFFICIENCY OF LOCAL APPLICATION OF AN ALKALINE BENEFICIAL AGENT 2015
  • Sun, Ying
  • Wu, Jeffrey M.
  • Fassih, Ali
RU2722783C2
ANHYDROUS POWDER AND LIQUID PARTICLES 2013
  • Fassikh Ali
  • Sun In
RU2640184C2
PHENYLEPHRINE RESINATE PARTICLES 2014
  • Li Der-Yan
  • Dzhelott Keti
RU2675788C2
COATED PHENYLEPHRINE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS 2014
  • Li Der-Yan
  • Chen Vinsent
  • Shen Robert
RU2681312C2
PHENYLEPHRINE RESINATE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS 2014
  • Li Der-Yan
  • Li Shun Por
RU2672731C2
ANTISPASMODIC 1,2-DIOLS AND 1,2,3-TRIOLS 2013
  • Shakh Mandar V.
  • Shakh Priti Sangkhvi
RU2657556C2
COMPOSITIONS AND METHODS OF TREATING CHRONIC INFLAMMATION AND INFLAMMATORY DISEASES 2014
  • Bannister Robin Mark
  • Bryu Dzhon
  • Kaparos-Uonderli Uilson
  • Dilli Syuzann Dzhejn
  • Plegesuelos Mateo Olga
  • Stoloff Gregori Alan
RU2680801C2
BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE 2015
  • Martin, Andrea K.
  • Kanski, Jaroslaw
  • Bera, Bindu
  • Bera, Sanjib
  • Guenther, Sven
  • Mickle, Travis
RU2683317C2
COMBINED THERAPY FOR IMMUNE DISEASE TREATMENT 2004
  • Dzhost-Prajs Ehdvard Rojdon
  • Brehsher Brehdli B.
  • Chehppel Todd V.
  • Manivasakam Palanijandi
  • Saks Noa
  • Smit Brendan
  • Auspitts Bendzhamin A.
RU2329037C2

RU 2 804 418 C2

Authors

Bagchi, Saumitra

Khasenmajer, Donald

Dates

2023-09-29Published

2018-11-28Filed